default author photo

Peter J. Houghton

University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute

One UTSA Circle

San Antonio, TX 78249

United States

SCHOLARLY PAPERS

2

DOWNLOADS

149

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

KRAS Suppression-Induced Degradation of MYC is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Number of pages: 80 Posted: 12 Apr 2018
University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, Translational Genomic Research Institute - Molecular Medicine Division, Van Andel Institute - Pathology and Biorepository Core, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, University of Helsinki - Institute for Molecular Medicine Finland (FIMM), University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, Translational Genomic Research Institute - Molecular Medicine Division, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Arizona - Department of Medicine, University of Arizona - Department of Medicine, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, University of Helsinki - Institute for Molecular Medicine Finland (FIMM), University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center and University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center
Downloads 76 (830,555)

Abstract:

Loading...

2.

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Number of pages: 70 Posted: 06 May 2019
University of Pennsylvania - Children's Hospital of Philadelphia, University of Pennsylvania - The Center for Data Driven Discovery in Biomedicine, Baylor College of Medicine - Human Genome Sequencing Center, Children's Hospital of Philadelphia - Division of Oncology, Baylor University - Human Genome Sequencing Center, Guardian Forensic Sciences, University of California, Santa Cruz - Genomics Institute, Children's Hospital of Philadelphia - Division of Oncology, Children's Hospital of Philadelphia - Division of Oncology, Children’s Hospital of Philadelphia - Division of Oncology, University of Pennsylvania - Genomics and Computational Biology Graduate Group, Children's Hospital of Philadelphia - Division of Oncology, Children's Hospital of Philadelphia - Department of Bioinformatics and Health Informatics, Children's Hospital of Philadelphia - Division of Oncology, Children's Hospital of Philadelphia - Department of Bioinformatics and Health Informatics, University of New South Wales (UNSW) - Children's Cancer Institute, Texas Tech University - Cancer Center, Texas Tech University - Cancer Center, University of New South Wales (UNSW) - Children's Cancer Institute, University of New South Wales (UNSW) - Children's Cancer Institute, University of New South Wales (UNSW) - Children's Cancer Institute, University of New South Wales (UNSW) - Children's Cancer Institute, University of New South Wales (UNSW) - Children's Cancer Institute, Sydney Children's Hospital, Children's Cancer Institute, Children's Hospital of Philadelphia - Department of Bioinformatics and Health Informatics, Baylor University - Texas Children's Cancer and Hematology Center, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, Baylor University - Preclinical Neurooncology Research Program, St. Jude Children’s Research Hospital - Department of Surgery, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, Research Institute at Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital, Research Institute at Nationwide Children's Hospital, Baylor University - Human Genome Sequencing Center, Baylor University - Human Genome Sequencing Center, University of Texas at Houston - Division of Pediatrics, University of Pennsylvania - Division of Oncology, University of Pennsylvania - Division of Oncology, University of Pennsylvania - Division of Oncology, University of Pennsylvania - Division of Oncology, RTI International - Department of Global Health Technologies, Dartmouth College - Department of Molecular and Systems Biology, Alex's Lemonade Stand Foundation - Childhood Cancer Data Lab, University of Pennsylvania - Division of Oncology, University of California, Santa Cruz - Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz - Howard Hughes Medical Institute, Nationwide Children's Hospital, University of California, Santa Cruz - Howard Hughes Medical Institute, University of Texas at Houston - Division of Pediatrics, Baylor University - Preclinical Neurooncology Research Program, Texas Tech University - Cancer Center, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, University of Texas at San Antonio, Health Science Center, Greehey Children's Cancer Research Institute, Government of the United States of America - National Cancer Institute, University of New South Wales (UNSW), Children’s Hospital of Philadelphia - Department of Biomedical and Health Informatics, Wildman Harrold and Children’s Hospital of Philadelphia - Division of Oncology
Downloads 73 (852,604)
Citation 1

Abstract:

Loading...

Pediatric cancer, patient-derived xenograft, relapse, whole exome sequencing, transcriptome sequencing, copy number profiling, preclinical testing, classifier